First case of 2019 novel coronavirus in the United States ML Holshue, C DeBolt, S Lindquist, KH Lofy, J Wiesman, H Bruce, ... New England journal of medicine 382 (10), 929-936, 2020 | 7703 | 2020 |
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 121-130, 2019 | 2277 | 2019 |
Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome Q Yu, R König, S Pillai, K Chiles, M Kearney, S Palmer, D Richman, ... Nature structural & molecular biology 11 (5), 435-442, 2004 | 743 | 2004 |
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 131-138, 2019 | 535 | 2019 |
Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak—United States, December 31, 2019–February 4, 2020 A Patel MMWR. Morbidity and mortality weekly report 69, 2020 | 511 | 2020 |
HIV rebounds from latently infected cells, rather than from continuing low-level replication B Joos, M Fischer, H Kuster, SK Pillai, JK Wong, J Böni, B Hirschel, ... Proceedings of the National Academy of Sciences 105 (43), 16725-16730, 2008 | 353 | 2008 |
Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient SA Yukl, E Boritz, M Busch, C Bentsen, TW Chun, D Douek, E Eisele, ... PLoS pathogens 9 (5), e1003347, 2013 | 346 | 2013 |
Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States Nature medicine 26 (6), 861-868, 2020 | 338 | 2020 |
Numbering positions in HIV relative to HXB2CG B Korber, BT Foley, C Kuiken, SK Pillai, JG Sodroski Human retroviruses and AIDS 3, 102-111, 1998 | 237 | 1998 |
Washington state 2019-nCoV case investigation team ML Holshue, C DeBolt, S Lindquist, KH Lofy, J Wiesman, H Bruce, ... First case of, 929-936, 2019 | 227 | 2019 |
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood DL Ng, GM Goldgof, BR Shy, AG Levine, J Balcerek, SP Bapat, J Prostko, ... Nature communications 11 (1), 4698, 2020 | 194 | 2020 |
A new perspective on V3 phenotype prediction S Pillai, B Good, D Richman, J Corbeil AIDS research and human retroviruses 19 (2), 145-149, 2003 | 181 | 2003 |
Current V3 genotyping algorithms are inadequate for predicting X4 co-receptor usage in clinical isolates AJ Low, W Dong, D Chan, T Sing, R Swanstrom, M Jensen, S Pillai, ... Aids 21 (14), F17-F24, 2007 | 179 | 2007 |
Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy MC Strain, S Letendre, SK Pillai, T Russell, CC Ignacio, HF Gunthard, ... Journal of virology 79 (3), 1772-1788, 2005 | 171 | 2005 |
In vivo CD8+ T-cell suppression of siv viremia is not mediated by CTL clearance of productively infected cells JK Wong, MC Strain, R Porrata, E Reay, S Sankaran-Walters, CC Ignacio, ... PLoS pathogens 6 (1), e1000748, 2010 | 168 | 2010 |
First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection … SR Bialek, D Allen, F Alvarado-Ramy, R Arthur, A Balajee, D Bell, S Best, ... American Journal of Transplantation 14 (7), 1693-1699, 2014 | 165 | 2014 |
Antibiotics in laboratory medicine SK Pillai, RC Moellering, GM Eliopoulos, V Lorian Antibiotics in Laboratory Medicine. 5th ed. Baltimore, MD: Lippincott …, 2005 | 157 | 2005 |
Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4+ T cells E Battivelli, MS Dahabieh, M Abdel-Mohsen, JP Svensson, ... Elife 7, e34655, 2018 | 151 | 2018 |
Update: interim guidance for preconception counseling and prevention of sexual transmission of Zika virus for persons with possible Zika virus exposure—United States … EE Petersen MMWR. Morbidity and mortality weekly report 65, 2016 | 151 | 2016 |
Short-course toll-like receptor 9 agonist treatment impacts innate immunity and plasma viremia in individuals with human immunodeficiency virus infection L Vibholm, MH Schleimann, JF Højen, T Benfield, R Offersen, ... Clinical Infectious Diseases 64 (12), 1686-1695, 2017 | 149 | 2017 |